Other interactions. Interactions and communications with any clinical trial site, investigator, subject, and/or Institutional Review Boards, as well as with any other manufacturing establishments and/or consignees pursuant to 21 C.F.R. § 1271.160 shall be governed by the Quality Agreement.
Appears in 2 contracts
Sources: Manufacturing Services Agreement (Iovance Biotherapeutics, Inc.), Manufacturing Services Agreement (Lion Biotechnologies, Inc.)